CITRASATE® — DIALYSIS CONCENTRATE DESIGNED FOR CLINICAL & OPERATIONAL ADVANTAGE
Citrasate® isn’t just a dialysis concentrate.
It’s a structural upgrade to how dialysis is delivered.
SHK Medical supplies Citrasate®, a clinically proven citrate-based dialysis concentrate that improves patient outcomes while reducing total operating cost — without compromising safety, quality, or compliance.
WHY CITRASATE® EXISTS
Traditional acetic-acid–based dialysates were not designed for today’s operational pressures.
They contribute to:
Higher heparin dependency
Increased inflammation
Greater infection risk
Higher drug and nursing time costs
Citrasate® was developed to address these issues at the system level, not as an incremental tweak.
CLINICALLY PROVEN DIFFERENCE
Citrasate® is:
Developed and manufactured in the USA (globally under licence)
US FDA registered
Supported by over 30 years of clinical studies
Clinical outcomes include:
Up to 55% reduction in heparin usage
Improved dialysis efficiency (Kt/V)
Reduced clotting and inflammation
Fewer post-dialysis complications
Better outcomes are not abstract — they show up in daily operations.
It reduces:
Drug dependency
Nursing intervention
Infection-related disruptions
Consumable and medication spend
For clinics, this translates into:
Lower per-treatment operating cost
More predictable workflows
Improved patient recovery and experience
Clinical benefit and operational efficiency move together.
OPERATIONAL IMPACT (WHERE IT REALLY MATTERS)
Citrasate® changes more than treatment chemistry.
This is especially critical in:
Africa
The Caribbean
Remote or high-cost supply markets
Lower logistics burden = lower structural cost.
LOGISTICS & COST ADVANTAGE (DRY CONCENTRATE)
Dry Citrasate® concentrate delivers a major logistics advantage:
1,200 treatment sessions in the space of 220 liquid sessions
Reduced shipping volume and cost
Less storage space required
No drum pump-off
No product waste
WHERE CITRASATE® WORKS BEST
Citrasate® is particularly effective for:
Clinics managing bleeding-risk patients
Operators facing high logistics costs
Markets with storage or shipping constraints
Dialysis systems under pressure to improve outcomes and margins
This is not a niche product.
It’s a better default.
SUPPORT & INTEGRATION
SHK Medical doesn’t just supply Citrasate®.
We support:
Transition planning
Staff training
Logistics integration
Ongoing operational alignment
Adoption succeeds when the system is ready.
